Hoey Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

Hoey Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.27K	Hold	12	–	–	﹤0.01%	331
2025 Q4	$2.04K	Hold	12	–	–	﹤0.01%	346
2025 Q3	$1.58K	Hold	12	–	–	﹤0.01%	348
2025 Q2	$1.27K	Hold	12	–	–	﹤0.01%	353
2025 Q1	$1.49K	Hold	12	–	–	﹤0.01%	312
2024 Q4	$1.48K	Sell	12 -130	-92%	-$15.3K	﹤0.01%	303
2024 Q3	$15.2K	Hold	142	–	–	﹤0.01%	184
2024 Q2	$15.2K	Buy	142 +22	+18%	+$2.42K	﹤0.01%	184
2024 Q1	$14.5K	Hold	120	–	–	﹤0.01%	191
2023 Q4	$14.8K	Hold	120	–	–	﹤0.01%	185
2023 Q3	$15.5K	Hold	120	–	–	0.01%	182
2023 Q2	$14.9K	Hold	120	–	–	﹤0.01%	187
2023 Q1	$17.6K	Hold	120	–	–	0.01%	187
2022 Q4	$19.1K	Hold	120	–	–	0.01%	178
2022 Q3	$16K	Hold	120	–	–	0.01%	202
2022 Q2	$19K	Hold	120	–	–	0.01%	157
2022 Q1	$19K	Hold	120	–	–	0.01%	140
2021 Q4	$15K	Hold	120	–	–	﹤0.01%	159
2021 Q3	$16K	Hold	120	–	–	﹤0.01%	151
2021 Q2	$21K	Buy	+120	New	+$20.8K	0.01%	139

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Hoey Investments's JAZZ Position: Q1 2026 in Review

Hoey Investments held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 12 shares worth $2.27K. The position accounts for ﹤0.01% of the portfolio, ranked #331.

Hoey Investments first reported a position in JAZZ in Q2 2021 and has held it in 20 quarters since. The position peaked at $21K in Q2 2021. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

Hoey Investments held 12 shares of Jazz Pharmaceuticals worth $2.27K as of Q1 2026.
Hoey Investments left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
Jazz Pharmaceuticals made up ﹤0.01% of Hoey Investments's portfolio in Q1 2026, its #331 holding.
Hoey Investments first reported a position in Jazz Pharmaceuticals in Q2 2021 and has held it in 20 quarters since.
Hoey Investments's Jazz Pharmaceuticals position peaked at $21K in Q2 2021.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Hoey Investments's 13F filing for Q1 2026, filed 29 Apr 2026.